Can a daily yogurt beat stomach bugs in kids?
NCT ID NCT06045494
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a yogurt containing LG21 probiotics can clear H. pylori infection in children aged 4-6. 140 kids were split into two groups: one ate the yogurt daily for 12 weeks, the other got no treatment. The main goal was to see if the yogurt could turn a positive stool test negative, meaning the infection was gone.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- yogurt with LG21 probiotic
- What this could lead to
- If effective, this yogurt could offer a simple, non-antibiotic way to clear H. pylori infection in young children.
- What could go wrong
- This is a small, non-randomized trial with no blinding, so results may be unreliable. The yogurt may not work, and dietary supplements are not regulated like drugs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
140 people
The number who actually took part.
- Started
-
Sep 2023
- Finished
-
Jan 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
4 to 6 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Preschooler aged 4-6 years * H. pylori positive * Drink milk or milk beverages regularly (more than three times a week) before joining the study * ICF signed * Parents or guardians agree not to participate in other interventional clinical studies during this study Exclusion Criteria: * Has potential metabolic class or chronic disease * Use of antibiotics within 7 days before allocation (as judged by the trial responsible physician) * People who have been treated for eradication of Helicobacter pylori * Pharmaceuticals, medicinal skin care products (medical external products) and health foods that may affect gastric symptoms have been commonly used since more than one month ago * Already under digestive system treatment * Has lactose intolerance or protein allergy * Those whose families had plans to leave Jinhua City during the study period * Fails to comply with the provisions of the protocol * Those who are deemed unsuitable as subjects by the physician
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for H.pylori infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kaitai Biotech Lab
Hangzhou, Zhejiang, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New Two-Drug combo shows promise against stomach bug
- Which test is better for detecting h. pylori?
- New stomach bug treatment shows promise in 14-Day trial
- Stomach bug treatment may lower bleeding risk for heart patients
- Scientists map h. Pylori's resistance to antibiotics
- Argon plasma zaps stomach bugs in new trial